Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada.
Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.
Mol Pharm. 2020 May 4;17(5):1470-1481. doi: 10.1021/acs.molpharmaceut.9b01043. Epub 2020 Apr 9.
Polymeric micellar nanoparticles represent versatile and biocompatible platforms for targeted drug delivery. However, tracking their biodistribution, stability, and clearance profile in vivo is challenging. The goal of this study was to prepare surface-modified micelles with peptide GE11 for targeting the epidermal growth factor receptor (EGFR). In vitro fluorescence studies demonstrated significantly higher internalization of GE11 micelles into EGFR-expressing HCT116 colon cancer cells versus EGFR-negative SW620 cells. Azo coupling chemistry of tyrosine residues in the peptide backbone with aryl diazonium salts was used to label the micelles with radionuclide Cu for positron emission tomography (PET) imaging. In vivo analysis of Cu-labeled micelles showed prolonged blood circulation and predominant hepatobiliary clearance. The biodistribution profile of EGFR-targeting GE11 micelles was compared with nontargeting HW12 micelles in HCT116 tumor-bearing mice. PET revealed increasing tumor-to-muscle ratios for both micelles over 48 h. Accumulation of GE11-containing micelles in HCT116 tumors was higher compared to HW12-decorated micelles. Our data suggest that the efficacy of image-guided therapies with micellar nanoparticles could be enhanced by active targeting, as demonstrated with cancer biomarker EGFR.
聚合物胶束纳米粒是一种具有多功能性和生物相容性的靶向药物传递平台。然而,在体内追踪其生物分布、稳定性和清除情况具有挑战性。本研究的目的是制备表面修饰的载肽 GE11 的胶束,用于靶向表皮生长因子受体 (EGFR)。体外荧光研究表明,与 EGFR 阴性的 SW620 细胞相比,GE11 胶束对表达 EGFR 的 HCT116 结肠癌细胞的内化作用明显更高。使用偶氮键合化学将肽骨架中的酪氨酸残基与芳基重氮盐结合,从而用放射性核素 Cu 标记胶束进行正电子发射断层扫描 (PET) 成像。Cu 标记胶束的体内分析表明,其血液循环时间延长,主要通过肝胆清除。在荷 HCT116 肿瘤的小鼠中,比较了靶向 EGFR 的 GE11 胶束与非靶向 HW12 胶束的生物分布情况。PET 显示,两种胶束在 48 小时内的肿瘤与肌肉比值均逐渐增加。与 HW12 修饰的胶束相比,GE11 载药胶束在 HCT116 肿瘤中的蓄积量更高。我们的数据表明,通过主动靶向可以增强载药胶束的图像引导治疗的疗效,这在癌症生物标志物 EGFR 中得到了验证。